RFK Jr. moves to phase out food dyes U.S. Health and Human Services Secretary RFK Jr. proposed on Tuesday to eliminate eight petroleum-based dyes from America’s food supply by next year.

The bill puts forth the proposed 2026 budget for several federal agencies including the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA).

June 18 (UPI) -- The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and possibly eradicate the disease.

As the Trump administration cuts thousands of jobs at the U.S. Food and Drug Administration, industry experts are urging Canada’s food safety agency to raise its risk assessment for U.S. imports ...

Back to Top Q2. What are the key features of the new Food Shock Window? The Food Shock Window under the emergency financing instruments, the Rapid Credit Facility (RCF) and Rapid Financing Instrument ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health.

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

Kraft Heinz and General Mills are removing synthetic food dyes from all U.S. products by 2027, aligning with new FDA regulations and growing consumer demand.

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health.

Products such as Doritos, Mountain Dew and Pop-Tarts would require warning labels under Senate Bill 25, which also would require nutrition education and physical activity in public schools.

Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months. FDA's long-standing accelerated approval program generally issues ...

Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months. FDA's long-standing accelerated approval program generally issues ...